Burning Rock Biotech Ltd (BNR) — Financial Flexibility Index
Burning Rock Biotech Ltd (BNR) has a Financial Flexibility Index of 0.10x as of March 2026. Free cash flow of $28.29 Million (operating CF $23.04 Million minus capex $5.25 Million) represents 0% of total liabilities ($285.29 Million). Also explore Burning Rock Biotech Ltd (BNR) equity growth momentum to track the company's year-over-year net asset growth rate.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Burning Rock Biotech Ltd Financial Flexibility Index (2017–2025)
Historical Financial Flexibility Index trend for Burning Rock Biotech Ltd across 9 annual periods. Check BNR PP&E to net assets ratio to assess the company's strategic physical and investment asset allocation.
Annual Financial Flexibility Index for Burning Rock Biotech Ltd (2017–2025)
Year-by-year free cash flow to debt coverage for Burning Rock Biotech Ltd. For the full company profile including market capitalisation, see market cap of Burning Rock Biotech Ltd.
| Year | Flexibility Index | Free Cash Flow (USD) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | -0.08x | $-23.19 Million | $-28.44 Million | $285.29 Million | ▲ +71.3% |
| 2024 | -0.28x | $-86.28 Million | $-92.26 Million | $304.48 Million | ▲ +68.8% |
| 2023 | -0.91x | $-246.40 Million | $-255.78 Million | $271.59 Million | ▲ +1.4% |
| 2022 | -0.92x | $-394.78 Million | $-456.81 Million | $429.13 Million | ▼ -50.7% |
| 2021 | -0.61x | $-264.44 Million | $-477.89 Million | $433.28 Million | ▼ -2563.5% |
| 2020 | 0.02x | $6.00 Million | $-73.54 Million | $242.02 Million | ▲ +123.6% |
| 2019 | -0.10x | $-182.31 Million | $-228.04 Million | $1.74 Billion | ▲ +17.5% |
| 2018 | -0.13x | $-124.06 Million | $-148.78 Million | $976.14 Million | ▲ +73.4% |
| 2017 | -0.48x | $-110.69 Million | $-133.70 Million | $231.85 Million | — |